文献速递慢性肾脏病

肥胖与慢性肾脏病关联的常规与遗传证据

Conventional and Genetic Evidence on the Association between Adiposity and CKD.
PubMed 文献 · J Am Soc Nephrol · 2020-10-30

基于英国生物银行281,228名参与者的数据,采用logistic回归和孟德尔随机化分析,发现腰臀比和BMI与CKD患病率存在关联,遗传分析提示关联大部分为因果,且糖尿病和血压等中介因素解释了大部分风险。

要点

  • 腰臀比每增加0.06和BMI每增加5 kg/m²,常规分析中CKD风险分别增加69%和58%。
  • 遗传预测的腰臀比和BMI每增加相应单位,CKD风险分别增加29%和49%。
  • 调整糖尿病和血压后,常规分析关联强度下降56%,遗传分析下降83%和69%。

核心结论

  • 遗传分析表明中心性和全身性肥胖与CKD的常规关联大部分为因果。
  • 常规方法低估了糖尿病、血压及其相关因素的中介作用。
  • 遗传方法提示这些中介因素解释了大部分肥胖相关CKD风险。

研究设计与样本

  • 研究使用281,228名英国生物银行参与者的数据,评估腰臀比和BMI与CKD患病率的相关性。
  • 常规分析采用logistic回归,遗传分析采用孟德尔随机化,使用394个腰臀比和773个BMI相关位点。
  • 通过调整测量值或遗传关联进行多变量孟德尔随机化,评估已知中介因素的作用。

主要发现

  • 18,034名(6.4%)参与者存在CKD证据。
  • 常规分析中,腰臀比每增加0.06和BMI每增加5 kg/m²,CKD odds ratio分别为1.69(95% CI 1.64-1.74)和1.58(95% CI 1.55-1.62)。
  • 孟德尔随机化分析中,遗传预测的腰臀比每增加0.06和BMI每增加5 kg/m²,CKD odds ratio分别为1.29(95% CI 1.20-1.38)和1.49(95% CI 1.39-1.59)。
  • 调整糖尿病和测量血压后,腰臀比和BMI关联的卡方值下降56%。
  • 多变量孟德尔随机化中介调整后,遗传预测的腰臀比和BMI模型的卡方值分别下降83%和69%。

临床怎么用

  • 临床应重视中心性肥胖和全身性肥胖作为CKD的可干预危险因素。
  • 管理肥胖相关CKD风险时,应同时针对糖尿病和血压等中介因素进行干预。

局限性

  • 研究基于英国生物银行参与者,结果外推需谨慎。
  • 常规分析可能受残余混杂影响,遗传分析依赖工具变量假设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The size of any causal contribution of central and general adiposity to CKD risk and the underlying mechanism of mediation are unknown. METHODS: Data from 281,228 UK Biobank participants were used to estimate the relevance of waist-to-hip ratio and body mass index (BMI) to CKD prevalence. Conventional approaches used logistic regression. Genetic analyses used Mendelian randomization (MR) and data from 394 waist-to-hip ratio and 773 BMI-associated loci. Models assessed the role of known mediators (diabetes mellitus and BP) by adjusting for measured values (conventional analyses) or genetic associations of the selected loci (multivariable MR). RESULTS: Evidence of CKD was found in 18,034 (6.4%) participants. Each 0.06 higher measured waist-to-hip ratio and each 5-kg/m2 increase in BMI were associated with 69% (odds ratio, 1.69; 95% CI, 1.64 to 1.74) and 58% (1.58; 1.55 to 1.62) higher odds of CKD, respectively. In analogous MR analyses, each 0.06-genetically-predicted higher waist-to-hip ratio was associated with a 29% (1.29; 1.20 to 1.38) increased odds of CKD, and each 5-kg/m2 genetically-predicted higher BMI was associated with a 49% (1.49; 1.39 to 1.59) increased odds. After adjusting for diabetes and measured BP, chi-squared values for associations for waist-to-hip ratio and BMI fell by 56%. In contrast, mediator adjustment using multivariable MR found 83% and 69% reductions in chi-squared values for genetically-predicted waist-to-hip ratio and BMI models, respectively. CONCLUSIONS: Genetic analyses suggest that conventional associations between central and general adiposity with CKD are largely causal. However, conventional approaches underestimate mediating roles of diabetes, BP, and their correlates. Genetic approaches suggest these mediators explain most of adiposity-CKD-associated risk.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Zhu P, Herrington WG, Haynes R, et al. Conventional and Genetic Evidence on the Association between Adiposity and CKD. J Am Soc Nephrol. 2020. PMID: 33127858. doi:10.1681/ASN.2020050679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。